Chlorhexidine Gluconate Solution Market

• In March 2022, Chlorhexidine Gluconate (CHG), the top antiseptic on the market, was used by Cardinal Health to introduce the first surgical incise drape.

• In November 2022, in a two-year quality improvement study recently released by Intermountain Primary Children's Hospital, Covalon Technologies Ltd. reported that their SurgiClear dressing was a critical component of an infection prevention bundle that drastically decreased surgical wound infections.

In this report, the Chlorhexidine Gluconate Solution Market has been segmented by Types, Formulation, Application, End User and Geography.

Chlorhexidine Gluconate Solution Market, Segmentation By Types

The Chlorhexidine Gluconate Solution Market has been segmented by Types into 2% Chlorhexidine Gluconate Solution and 4% Chlorhexidine Gluconate Solution.

2% Chlorhexidine Gluconate Solution

The 2% Chlorhexidine Gluconate Solution segment holds nearly 55% of the market share, primarily driven by its application in surgical scrubs and routine skin disinfection. Its lower concentration ensures safety for daily use, making it a preferred choice in hospitals and outpatient care facilities.

4% Chlorhexidine Gluconate Solution

The 4% Chlorhexidine Gluconate Solution segment accounts for approximately 45% of the global demand. It is widely utilized in preoperative skin preparation and infection prevention due to its stronger antimicrobial effect. The rising emphasis on reducing healthcare-associated infections (HAIs) is fueling adoption in ICUs and surgical departments.

Chlorhexidine Gluconate Solution Market, Segmentation By Formulation

The Chlorhexidine Gluconate Solution Market has been segmented by Formulation into Solution and Gel.

Solution

The solution form dominates the chlorhexidine gluconate solution market, accounting for nearly 70% of the total demand. Its popularity is driven by its wide use in hospitals, clinics, and dental practices for effective infection control and wound cleaning. The liquid solution format is preferred due to its easy application, quick action, and compatibility with medical procedures, making it the most widely adopted formulation globally.

Gel

The gel formulation holds around 30% of the market share and is increasingly used in dental care, surgical procedures, and skin infection management. Its ability to provide localized application with prolonged antimicrobial activity makes it a favorable choice in specific medical settings. Rising adoption in oral healthcare and dermatology is expected to further boost the demand for gel-based chlorhexidine gluconate products in the coming years.

Chlorhexidine Gluconate Solution Market, Segmentation By Application

The Chlorhexidine Gluconate Solution Market has been segmented by Application into Preoperative Skin Preparation, Surgical Hand Scrub, Healthcare Personnel Hand Hygiene and Skin Wound & General Skin Cleanser.

Preoperative Skin Preparation

The preoperative skin preparation segment leads usage, contributing an estimated 37% of demand. Hospitals prioritize it for broad-spectrum antisepsis and consistent protocol compliance before invasive procedures. Growth is supported by rising surgical volumes and stricter infection control standards that favor CHG over alternatives for persistent activity on the skin.

Surgical Hand Scrub

Surgical hand scrub applications account for roughly 28% of the market. Operating teams value CHG for its rapid kill and residual protection across extended procedure times. Adoption continues to climb with standardized perioperative hygiene programs and measurable reductions in contamination risk across high-acuity settings.

Healthcare Personnel Hand Hygiene

The healthcare personnel hand hygiene segment represents about 22% of usage. Facilities deploy CHG-based products to enhance everyday compliance, particularly in critical care and isolation units. Demand is reinforced by continuous training, hospital-wide protocols, and the need for reliable antimicrobial efficacy during frequent hand sanitation events.

Skin Wound & General Skin Cleanser

Skin wound & general skin cleanser applications contribute close to 13% of the market. Clinicians select CHG for localized antisepsis, routine cleansing, and adjunct care in minor procedures. Uptake is supported by outpatient and home-care trends where easy application and proven microbial control improve patient management and outcomes.

Chlorhexidine Gluconate Solution Market, Segmentation By End User

The Chlorhexidine Gluconate Solution Market has been segmented by End User into Hospitals and Clinics.

Hospitals

The hospitals segment accounts for nearly 68% of the chlorhexidine gluconate solution market, making it the largest end-user category. Hospitals prefer CHG solutions due to their proven efficacy in infection prevention, especially during surgeries and intensive care treatments. The high patient inflow and stringent infection control protocols continue to drive steady demand from this segment.

Clinics

Clinics represent about 32% of market consumption, with adoption increasing due to rising awareness of antimicrobial solutions in outpatient and day-care procedures. CHG solutions are widely used in wound care, dermatology, and dental practices, where their localized effectiveness and cost efficiency make them a preferred choice. Expanding clinic networks worldwide are expected to strengthen this segment’s growth.

Chlorhexidine Gluconate Solution Market, Segmentation By Geography

In this report, the Chlorhexidine Gluconate Solution Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

Chlorhexidine Gluconate Solution Market Share (%), By Geographical Region

North America

North America holds the largest share of the chlorhexidine gluconate solution market, accounting for nearly 34%. The region’s dominance is fueled by advanced healthcare infrastructure, high surgical volumes, and strict infection control regulations. Widespread adoption across hospitals and outpatient facilities continues to strengthen its position.

Europe

Europe contributes around 27% of the global demand, supported by well-established healthcare systems and increasing preoperative antiseptic use. Rising awareness about hospital-acquired infections and strong government-backed healthcare policies are driving sustained growth in the region.

Asia Pacific

The Asia Pacific region commands about 24% of the market, emerging as the fastest-growing segment. Expansion is driven by rising healthcare investments, a growing patient population, and increasing surgical procedures. Developing economies like India and China are showing significant uptake of CHG solutions across hospitals and clinics.

Middle East & Africa

Middle East & Africa together account for nearly 8% of market share. Growth is influenced by improving healthcare infrastructure, rising awareness of infection control, and gradual adoption of advanced antiseptic solutions. However, limited accessibility in rural areas continues to be a challenge.

Latin America

Latin America represents close to 7% of the market. Adoption is being supported by expanding private healthcare facilities, growing prevalence of surgical treatments, and increasing emphasis on antimicrobial hygiene practices. Brazil and Mexico remain key contributors to the regional market growth.